Sean W Fanning (Sean Fanning, S W Fanning)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 18

Top Venues

Endocrinology

eLife

NPJ breast cancer

Nature communications

Northern Illinois University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Northern Illinois University Aug 01 2008 - May 01 2012

United States

PHD :: Chemistry and Biochemistry

Publications

Rachid Safi, Suzanne E Wardell, Paige Watkinson, Xiaodi Qin, Marissa Lee, Sunghee Park, Taylor Krebs, Emma L Dolan, Adam Blattler, Toshiya Tsuji, Surendra Nayak, Marwa Khater, Celia Fontanillo, Madeline A Newlin, Megan L Kirkland, Yingtian Xie, Henry W Long, Emma C Fink, Sean W Fanning, Scott Runyon, Myles A Brown, Shuichan Xu, Kouros Owzar, John D Norris, Donald P McDonnell
Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells. Nature communications 15 (1) (2024)
Rachid Safi, Suzanne E Wardell, Paige Watkinson, Xiaodi Qin, Marissa Lee, Sunghee Park, Taylor Krebs, Emma L Dolan, Adam Blattler, Toshiya Tsuji, Surendra Nayak, Marwa Khater, Celia Fontanillo, Madeline A Newlin, Megan L Kirkland, Yingtian Xie, Henry W Long, Emma C Fink, Sean W Fanning, Scott Runyon, Myles A Brown, Shuichan Xu, Kouros Owzar, John D Norris, Donald P McDonnell
Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells. Nature communications 15 (1) (2024)
Govinda R Hancock, Jason Gertz, Rinath Jeselsohn, Sean W Fanning
Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies. Endocrinology 165 (6) (2024)
Govinda R Hancock, Jason Gertz, Rinath Jeselsohn, Sean W Fanning
Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies. Endocrinology 165 (6) (2024)
Govinda R Hancock, Jason Gertz, Rinath Jeselsohn, Sean W Fanning
Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies. Endocrinology 165 (6) (2024)
Govinda R Hancock, Jason Gertz, Rinath Jeselsohn, Sean W Fanning
Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies. Endocrinology 165 (6) (2024)
Govinda R Hancock, Jason Gertz, Rinath Jeselsohn, Sean W Fanning
Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies. Endocrinology 165 (6) (2024)
Govinda R Hancock, Jason Gertz, Rinath Jeselsohn, Sean W Fanning
Estrogen receptor alpha mutations, truncations, heterodimers, and therapies. Endocrinology (2024)
Govinda R Hancock, Jason Gertz, Rinath Jeselsohn, Sean W Fanning
Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies. Endocrinology 165 (6) (2024)
Kristen S Young, Sean W Fanning
Alternative activation. eLife 12 (2023)
G R Hancock, K S Young, D J Hosfield, C Joiner, E A Sullivan, Y Yildiz, M Lainé, Geoffrey L Greene, Sean W Fanning
Unconventional isoquinoline-based SERMs elicit fulvestrant-like transcriptional programs in ER+ breast cancer cells. NPJ breast cancer 8 (1) (2022)
Thomas E Speltz, Zeyu Qiao, Colin S Swenson, Xianghang Shangguan, John S Coukos, Christopher W Lee, Deborah M Thomas, Jesse Santana, Sean W Fanning, Geoffrey L Greene, Raymond E Moellering
Targeting MYC with modular synthetic transcriptional repressors derived from bHLH DNA-binding domains. Nature biotechnology (2022)
David J Hosfield, Sandra Weber, Nan-Sheng Li, Madline Sauvage, Carstyn F Joiner, Govinda R Hancock, Emily A Sullivan, Estelle Ndukwe, Ross Han, Sydney Cush, Muriel Lainé, Sylvie C Mader, Geoffrey L Greene, Sean W Fanning
Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in ESR1 mutant breast cancer cells. eLife 11 (2022)
G R Hancock, K S Young, D J Hosfield, C Joiner, E A Sullivan, Y Yildiz, M Lainé, Geoffrey L Greene, Sean W Fanning
Unconventional isoquinoline-based SERMs elicit fulvestrant-like transcriptional programs in ER+ breast cancer cells. NPJ breast cancer 8 (1) (2022)
Matthew W Boudreau, Darjan Duraki, Lawrence Wang, Chengjian Mao, Ji Eun Kim, Madeline A Henn, Bingtao Tang, Sean W Fanning, Jeffrey Kiefer, Theodore M Tarasow, Elizabeth M Bruckheimer, Ramon Moreno, Spyro Mousses, Geoffrey L Greene, Edward J Roy, Ben Ho Park, Timothy M Fan, Erik Russell Nelson, Paul J Hergenrother, David J Shapiro
A small-molecule activator of the unfolded protein response eradicates human breast tumors in mice. Science translational medicine 13 (603) (2021)
Christopher G Mayne, Weiyi Toy, Kathryn E Carlson, Trusha Bhatt, Sean W Fanning, Geoffrey L Greene, Benita S Katzenellenbogen, Sarat Chandarlapaty, John A Katzenellenbogen, Emad Tajkhorshid
Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast Cancer. Molecular cancer research : MCR 19 (9) (2021)
Sean W Fanning, Rinath Jeselsohn, Venkatasubramanian Dharmarajan, Christopher G Mayne, Mostafa Karimi, Gilles Buchwalter, René Houtman, Weiyi Toy, Colin E Fowler, Ross Han, Muriel Lainé, Kathryn E Carlson, Teresa A Martin, Jason Nowak, Jerome C Nwachukwu, David J Hosfield, Sarat Chandarlapaty, Emad Tajkhorshid, Kendall W Nettles, Patrick R Griffin, Yang Shen, John A Katzenellenbogen, Myles A Brown, Geoffrey L Greene
The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells. eLife 7 (2018)
Sean W Fanning, Christopher G Mayne, Venkatasubramanian Dharmarajan, Kathryn E Carlson, Teresa A Martin, Scott J Novick, Weiyi Toy, Bradley Green, Srinivas Panchamukhi, Benita S Katzenellenbogen, Emad Tajkhorshid, Patrick R Griffin, Yang Shen, Sarat Chandarlapaty, John A Katzenellenbogen, Geoffrey L Greene
Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation. eLife 5 (2016)

Sean W Fanning.css-eqlu8i{font-size:small;padding-left:4px;} (Sean Fanning, S W Fanning)

Publication Activity (10 Years)

Top Topics

Top Venues

Sean W Fanning (Sean Fanning, S W Fanning)